We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-0.13%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$7.41B
AUM Growth
-$1.63B
Cap. Flow
-$1.27B
Cap. Flow %
-17.2%
Top 10 Hldgs %
9.76%
Holding
2,951
New
679
Increased
670
Reduced
594
Closed
919

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$60.6M
2
CSGP icon
CoStar Group
CSGP
+$57.8M
3
ED icon
Consolidated Edison
ED
+$52.3M
4
DE icon
Deere & Co
DE
+$44.5M
5
EXC icon
Exelon
EXC
+$42.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$483M
2
AMZN icon
Amazon
AMZN
+$366M
3
MRNA icon
Moderna
MRNA
+$123M
4
ETR icon
Entergy
ETR
+$44.9M
5
LIN icon
Linde
LIN
+$43.7M

Sector Composition

Rank Sector Weight
1 Technology 16.98%
2 Industrials 10.54%
3 Consumer Discretionary 9.76%
4 Financials 9.11%
5 Healthcare 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHNG
1826
CALL
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$159K ﹤0.01%
7,500
+2,500
+50% +$54.5K
AGEN
1827
Agenus
AGEN
$345M
$158K ﹤0.01%
1,536
+339
+28% +$38.3K
ATNM icon
1828
Actinium Pharmaceuticals
ATNM
$32.9M
$158K ﹤0.01%
+17,800
New +$124K
CSPR
1829
DELISTED
Casper Sleep Inc.
CSPR
$158K ﹤0.01%
37,021
-29,375
-44% -$176K
ATCO
1830
DELISTED
Atlas Corp.
ATCO
$155K ﹤0.01%
10,190
-57,796
-85% -$826K
HMHC
1831
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$155K ﹤0.01%
11,562
-3,923
-25% -$49.4K
CGEN icon
1832
Compugen
CGEN
$245M
$153K ﹤0.01%
25,658
+15,206
+145% +$102K
VKTX icon
1833
Viking Therapeutics
VKTX
$3.88B
$153K ﹤0.01%
24,405
-51,235
-68% -$317K
RYTM icon
1834
Rhythm Pharmaceuticals
RYTM
$7.67B
$152K ﹤0.01%
11,601
-3,343
-22% -$51.1K
ATRS
1835
DELISTED
Antares Pharma, Inc.
ATRS
$152K ﹤0.01%
41,888
-4,955
-11% -$20K
FLL icon
1836
Full House Resorts
FLL
$78.4M
$151K ﹤0.01%
14,269
-2,383
-14% -$20.3K
ELMS
1837
DELISTED
Electric Last Mile Solutions, Inc. Class A Common stock
ELMS
$151K ﹤0.01%
+20,400
New +$175K
GTBP icon
1838
GT Biopharma
GTBP
$13.8M
$150K ﹤0.01%
+740
New +$223K
EVC icon
1839
Entravision Communication
EVC
$748M
$149K ﹤0.01%
+20,933
New +$141K
SLI
1840
Standard Lithium
SLI
$600M
$149K ﹤0.01%
+18,300
New +$121K
FWONK icon
1841
Liberty Media Series C
FWONK
$26.7B
$148K ﹤0.01%
2,980
+1,388
+87% +$65.7K
WTI icon
1842
W&T Offshore
WTI
$574M
$148K ﹤0.01%
+39,856
New +$142K
YPF icon
1843
YPF Sociedad Anonima ADS
YPF
$20.1B
$148K ﹤0.01%
31,794
+1,670
+6% +$7.81K
HLTH
1844
DELISTED
Cue Health Inc. Common Stock
HLTH
$148K ﹤0.01%
+12,500
New +$197K
DGNU
1845
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$147K ﹤0.01%
15,000
ATER icon
1846
Aterian
ATER
$7.96M
$146K ﹤0.01%
+1,125
New +$125K
FCF icon
1847
First Commonwealth Financial
FCF
$2.12B
$146K ﹤0.01%
10,722
-23,600
-69% -$315K
LFMD icon
1848
LifeMD
LFMD
$151M
$145K ﹤0.01%
23,418
+6,466
+38% +$55.2K
LGF.B
1849
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$142K ﹤0.01%
+10,920
New +$144K
CLSD
1850
DELISTED
Clearside Biomedical
CLSD
$141K ﹤0.01%
+1,566
New +$138K

Similar funds

Michael Gelband's Q3 2021 Portfolio in Review

As of Q3 2021, Michael Gelband held 2,951 positions worth $7.41B, down 18% from $9.04B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Michael Gelband withdrew a net $1.27B in Q3 2021, closing 919 positions and reducing 594 holdings. Its most notable exit was Amazon, an estimated $366M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Michael Gelband opened a new position in Advanced Micro Devices worth $61M.

  • Michael Gelband's largest Q3 2021 buy was Advanced Micro Devices: 592,990 shares worth $61M.
  • Michael Gelband added most to CoStar Group in Q3 2021, an estimated $57.8M increase.
  • Michael Gelband's biggest Q3 2021 reduction was Microsoft, cutting an estimated $483M.
  • Michael Gelband fully exited Amazon in Q3 2021, selling an estimated $366M.
  • Michael Gelband's ten largest holdings make up 9.8% of its $7.41B portfolio in Q3 2021.
  • Michael Gelband opened 679 new positions and closed 919 in Q3 2021.
  • Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.41B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.